Menatallah M. Youssef

Dr. Menatallah M. Youssef

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
MAMaha F. Abdel-Ghany
Maha F. Abdel-Ghany
LHLobna A. Hussein
Lobna A. Hussein
Miriam AyadMiriam Ayad
Miriam Ayad
MYMenatallah M. Youssef
Menatallah M. Youssef

24 January 2018 in Separations
Verified
Journal Article
Open access
PDF file
MSMansi Shah
Mansi Shah
LBLuke Bourner
Luke Bourner
SAShariq Ali
Shariq Ali
SASanaalarab Al-Enazy
Sanaalarab Al-Enazy
MYMenatallah M. Youssef
Menatallah M. Youssef
ERErik Rytting
Erik Rytting
Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R2 values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.